Abstract

Fibromyalgia

Author(s): Oberlander Kevin

Issue: Jan/Feb 2000 - Compounding for Pain Management

Page(s): 21-23

Download in electronic PDF format for $75

Abstract

Fibromyalgia is a collection of symptoms with an unknown cause. In this article, the author focuses on symptoms and treatment regimen (dietary recommendations, exercise, sleep, stress, nutritional support and topical treatments). A sidebar shows the body’s tender points and describes their location. The author concludes that if individuals and their physicians are willing to be persistent and integrate conventional practice with the tools of the compounding pharmacist, the patient will improve.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2000 Pg. 21-23	Fibromyalgia Author(s): Oberlander Kevin
Nov/Dec 2010 Pg. 512	Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 234	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 136	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 245	Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 157	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 131	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 101-105	Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
May/Jun 2020 Pg. 227	Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 193-199	The Role of Sex Hormones on Fibromyalgia Pain Mediators Author(s): Bramwell Bethany L
May/Jun 2018 Pg. 252-256	The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia Author(s): Cote Brianna, Ross Bethany, Fortner Jeff, Rao Deepa
Nov/Dec 2008 Pg. 540	Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 1998 Pg. 433	Topical Ketoprofen for Fibromyalgia Author(s): Manuel Julie, Ford Gina
Nov/Dec 2010 Pg. 513	Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 514	Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 133	Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 172-175	Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Author(s): Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
May/Jun 2016 Pg. 250-256	Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Author(s): Trimble John, Light Bob
May/Jun 2016 Pg. 231	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 313	Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream Author(s): Allen Loyd V Jr